Literature DB >> 15731724

Scar management after breast surgery: preliminary results of a prospective, randomized, and double-blind clinical study with aldara cream 5% (imiquimod).

Arturo Prado, Patricio Andrades, Susana Benitez, Miguel Umaña.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2005        PMID： 15731724     DOI： 10.1097/01.prs.0000153823.52784.7e

Source DB:  PubMed          Journal:  Plast Reconstr Surg        ISSN： 0032-1052            Impact factor:   4.730


× No keyword cloud information.
  6 in total

Review 1.  Hypertrophic scarring and keloids: pathomechanisms and current and emerging treatment strategies.

Authors:  Gerd G Gauglitz; Hans C Korting; Tatiana Pavicic; Thomas Ruzicka; Marc G Jeschke
Journal:  Mol Med       Date:  2010-10-05       Impact factor: 6.354

2.  The role of Th1/Th2 cell chemokine expression in hypertrophic scar.

Authors:  Baoguo Chen; Huichao Li; Wei Xia
Journal:  Int Wound J       Date:  2019-11-05       Impact factor: 3.315

3.  Establishment of an efficacious treatment period for prophylaxis of auricular keloid recurrence postexcision using topical imiquimod 5%: A demonstrative case series.

Authors:  Lina J Chan; Harry L Greenberg
Journal:  JAAD Case Rep       Date:  2022-06-30

Review 4.  Update on Keloid Management: Clinical and Basic Science Advances.

Authors:  Martha H Viera; Alejandra C Vivas; Brian Berman
Journal:  Adv Wound Care (New Rochelle)       Date:  2012-10       Impact factor: 4.730

Review 5.  A comprehensive evidence-based review on the role of topicals and dressings in the management of skin scarring.

Authors:  G P Sidgwick; D McGeorge; A Bayat
Journal:  Arch Dermatol Res       Date:  2015-06-05       Impact factor: 3.017

Review 6.  Current Therapeutic Approach to Hypertrophic Scars.

Authors:  Zrinka Bukvić Mokos; Anamaria Jović; Lovorka Grgurević; Ivo Dumić-Čule; Krešimir Kostović; Romana Čeović; Branka Marinović
Journal:  Front Med (Lausanne)       Date:  2017-06-20
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.